Your browser doesn't support javascript.
Health information use by patients with systemic lupus erythematosus (SLE) pre and during the COVID-19 pandemic.
Cardwell, Francesca S; Elliott, Susan J; Chin, Ricky; St Pierre, Yvan; Choi, May Y; Urowitz, Murray B; Ruiz-Irastorza, Guillermo; Bernatsky, Sasha; Wallace, Daniel J; Petri, Michelle A; Manzi, Susan; Bae, Sang-Cheol; Shin, Jung-Min; Mak, Anselm; Cho, Jiacai; Peschken, Christine A; Ramsey-Goldman, Rosalind; Fortin, Paul R; Hanly, John G; Pons-Estel, Bernardo A; Nieto, Romina; Askanase, Anca D; Romero-Diaz, Juanita; Mosca, Marta; Bruce, Ian N; Rowbottom, Leigha; Mielczarek, Leanne; Tse, Karin; Marion, Ashley; Cáhiz-González, Juan Carlos; Cattoni, Teresa G; Cornet, Alain; Clarke, Ann Elaine.
  • Cardwell FS; Geography and Environmental Management, University of Waterloo, Waterloo, Ontario, Canada fcardwel@uwaterloo.ca.
  • Elliott SJ; Geography and Environmental Management, University of Waterloo, Waterloo, Ontario, Canada.
  • Chin R; Division of Rheumatology, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada.
  • St Pierre Y; Division of Clinical Epidemiology, Department of Medicine, McGill University Health Centre, Montreal, Quebec, Canada.
  • Choi MY; Division of Rheumatology, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada.
  • Urowitz MB; Schroeder Arthritis Institute, Kremblin Research Institute, University of Toronto, Toronto, Ontario, Canada.
  • Ruiz-Irastorza G; Autoimmune Diseases Research Unit, BioCruces Bizkaia Health Research Institute, University of the Basque Country, Barakaldo, Bizkaia, Spain.
  • Bernatsky S; Department of Medicine and Centre for Outcomes Research & Evaluation, McGill University, Montreal, Quebec, Canada.
  • Wallace DJ; Rheumatology, Cedars-Sinai Medical Center, West Hollywood, California, USA.
  • Petri MA; Division of Rheumatology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
  • Manzi S; Lupus Center of Excellence, Allegheny Health Network, Pittsburgh, Pennsylvania, USA.
  • Bae SC; Department of Rheumatology, Hanyang University Seoul Hospital, Seoul, The Republic of Korea.
  • Shin JM; Department of Rheumatology, Hanyang University, Seongdong-gu, Seoul, The Republic of Korea.
  • Mak A; Department of Medicine, Yong Loo Lin School of Medicine, National University of Singapore, Singapore.
  • Cho J; Division of Rheumatology, Department of Medicine, National University Hospital, Singapore.
  • Peschken CA; Department of Medicine, Yong Loo Lin School of Medicine, National University of Singapore, Singapore.
  • Ramsey-Goldman R; Division of Rheumatology, Department of Medicine, National University Hospital of Singapore, Singapore.
  • Fortin PR; Max Rady College of Medicine, Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, Manitoba, Canada.
  • Hanly JG; Feinberg School of Medicine, Northwestern University, Chicago, Illinois, USA.
  • Pons-Estel BA; Medicine-Rheumatology, Centre Hospitalier de l'Université Laval, Quebec City, Quebec, Canada.
  • Nieto R; Division of Rheumatology, Department of Medicine, Queen Elizabeth II Health Sciences Center and Dalhousie University, Halifax, Nova Scotia, Canada.
  • Askanase AD; Rheumatology, Centro Regional de Enfermedades Autoinmunes y Reumáticas (CREAR), Rosario, Argentina.
  • Romero-Diaz J; Department of Rheumatology, Centro Regional de Enfermedades Autoinmunes y Reumáticas (CREAR), Rosario, Argentina.
  • Mosca M; Columbia University Medical Center, New York, New York, USA.
  • Bruce IN; Immunology and Rheumatology, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico.
  • Rowbottom L; Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.
  • Mielczarek L; Arthritis Research UK Centre for Epidemiology, The University of Manchester, Manchester, UK.
  • Tse K; Division of Rheumatology, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada.
  • Marion A; Lupus Canada, Newmarket, Ontario, Canada.
  • Cáhiz-González JC; Lupus Foundation of America Inc, Washington, District of Columbia, USA.
  • Cattoni TG; Lupus Foundation of America Inc, Washington, District of Columbia, USA.
  • Cornet A; Federación Española de Lupus, Madrid, Spain.
  • Clarke AE; Asociación Lupus Argentina, Buenos Aires, Argentina.
Lupus Sci Med ; 9(1)2022 10.
Article in English | MEDLINE | ID: covidwho-2088871
ABSTRACT

OBJECTIVE:

We conducted an international survey of patients with SLE to assess their access, preference and trust in various health information sources pre-COVID-19 and during the COVID-19 pandemic.

METHODS:

Patients with SLE were recruited from 18 observational cohorts, and patients self-reporting SLE were recruited through five advocacy organisations. Respondents completed an online survey from June 2020 to December 2021 regarding the sources of health information they accessed in the 12 months preceding (pre-11 March 2020) and during (post-11 March 2020) the pandemic. Multivariable logistic regressions assessed factors associated with accessing news and social media post-11 March 2020, and self-reporting negative impacts from health information accessed through these sources.

RESULTS:

Surveys were completed by 2111 respondents; 92.8% were female, 76.6% had postsecondary education, mean (SD) age was 48.8 (14.0) years. Lupus specialists and family physicians were the most preferred sources pre-11 March 2020 and post-11 March 2020, yet were accessed less frequently (specialists 78.5% pre vs 70.2% post, difference -8.3%, 95% CI -10.2% to -6.5%; family physicians 57.1% pre vs 50.0% post, difference -7.1%, 95% CI -9.2% to -5.0%), while news (53.2% pre vs 62.1% post, difference 8.9%, 95% CI 6.7% to 11.0%) and social media (38.2% pre vs 40.6% post, difference 2.4%, 95% CI 0.7% to 4.2%) were accessed more frequently post-11 March 2020 vs pre-11 March 2020. 17.2% of respondents reported negative impacts from information accessed through news/social media. Those outside Canada, older respondents or with postsecondary education were more likely to access news media. Those in Asia, Latin America or younger respondents were more likely to access social media. Those in Asia, older respondents, males or with postsecondary education in Canada, Asia or the USA were less likely to be negatively impacted.

CONCLUSIONS:

Physicians, the most preferred and trusted sources, were accessed less frequently, while news and social media, less trusted sources, were accessed more frequently post-11 March 2020 vs pre-11 March 2020. Increasing accessibility to physicians, in person and virtually, may help reduce the consequences of accessing misinformation/disinformation.
Subject(s)
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: Social Media / COVID-19 / Lupus Erythematosus, Systemic Type of study: Cohort study / Experimental Studies / Observational study / Prognostic study Limits: Female / Humans / Male / Middle aged Language: English Year: 2022 Document Type: Article Affiliation country: Lupus-2022-000755

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Social Media / COVID-19 / Lupus Erythematosus, Systemic Type of study: Cohort study / Experimental Studies / Observational study / Prognostic study Limits: Female / Humans / Male / Middle aged Language: English Year: 2022 Document Type: Article Affiliation country: Lupus-2022-000755